GERON CORP Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate
GERON CORP (GERN) reported Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate of 0.04% for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-11.
Discontinued › Notes › Compensation Related Costs
us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate · last filed 2015-03-11
- GERON CORP share-based goods and nonemployee services transaction, valuation method, risk free interest rate for the quarter ending 2014-03-31 was 0.13%, a 48.00% decline year-over-year.
- GERON CORP share-based goods and nonemployee services transaction, valuation method, risk free interest rate for the quarter ending 2013-03-31 was 0.25%.
- GERON CORP share-based goods and nonemployee services transaction, valuation method, risk free interest rate for fiscal 2014 was 0.04%, a 69.23% decline from fiscal 2013.
- GERON CORP share-based goods and nonemployee services transaction, valuation method, risk free interest rate for fiscal 2013 was 0.13%, a 48.00% decline from fiscal 2012.
- GERON CORP share-based goods and nonemployee services transaction, valuation method, risk free interest rate for fiscal 2012 was 0.25%, a 30.56% decline from fiscal 2011.
- GERON CORP share-based goods and nonemployee services transaction, valuation method, risk free interest rate for fiscal 2011 was 0.36%.
| Period end | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate 3 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate 6 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate 9 month | Share-based Goods and Nonemployee Services Transaction, Valuation Method, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2014-12-31 | 0.04% 10-K · filed 2015-03-11 | |||
| 2014-09-30 | 0.03% 10-Q · filed 2014-11-05 | |||
| 2014-06-30 | 0.11% 10-Q · filed 2014-08-11 | |||
| 2014-03-31 | 0.13% 10-Q · filed 2014-05-01 | |||
| 2013-12-31 | 0.13% 10-K · filed 2015-03-11 | |||
| 2013-09-30 | 0.33% 10-Q · filed 2013-11-07 | |||
| 2013-06-30 | 0.36% 10-Q · filed 2013-08-08 | |||
| 2013-03-31 | 0.25% 10-Q · filed 2013-05-03 | |||
| 2012-12-31 | 0.25% 10-K · filed 2014-03-17 | |||
| 2012-09-30 | 0.31% 10-Q · filed 2012-11-02 | |||
| 2012-06-30 | 0.41% 10-Q · filed 2012-08-03 | |||
| 2011-12-31 | 0.36% 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |